Weiss Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
1CP
FHA
RJA
WAM
NIM
CA
Weiss Asset Management's HQL Position: Q1 2023 in Review
Weiss Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q1 2023, closing a stake of 28,350 shares — an estimated $403K sold.
Weiss Asset Management first reported a position in HQL in Q2 2014 and held it in 8 quarters. The position peaked at $2.25M in Q2 2014. 78 funds tracked by Wall St. Rank hold HQL as of Q1 2023.
- Weiss Asset Management reported no remaining abrdn Life Sciences Investors position as of Q1 2023 after selling out during the quarter.
- Weiss Asset Management sold 28,350 abrdn Life Sciences Investors shares in Q1 2023, an estimated $403K.
- Weiss Asset Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 8 quarters.
- Weiss Asset Management's abrdn Life Sciences Investors position peaked at $2.25M in Q2 2014.
- 78 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2023.
Based on Weiss Asset Management's 13F filing for Q1 2023, filed 10 May 2023.